| Bridgette A Bumann, CRNA | |
|
801 Broadway N, Fargo, ND 58102-3641 | |
| (701) 234-5621 | |
| Not Available |
| Full Name | Bridgette A Bumann |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 801 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447613021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R36443 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
Magnet hospitals, while widely recognized for better patient safety and outcomes, don't provide better working conditions for nurses than non-magnet hospitals, according to a new study by the University of Maryland School of Nursing.
Preclinical trials indicate that a drug candidate called OxaliTex can stop the growth of cancer cells completely. OxaliTex appears to be more potent than many other common chemotherapy drugs, with less toxicity and less rapidly counteracted by mechanisms of drug resistance. The study was reported in the journal Proceedings of the National Academy of Sciences in March 2020.
In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.
Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.
MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.
› Verified 2 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
Magnet hospitals, while widely recognized for better patient safety and outcomes, don't provide better working conditions for nurses than non-magnet hospitals, according to a new study by the University of Maryland School of Nursing.
Preclinical trials indicate that a drug candidate called OxaliTex can stop the growth of cancer cells completely. OxaliTex appears to be more potent than many other common chemotherapy drugs, with less toxicity and less rapidly counteracted by mechanisms of drug resistance. The study was reported in the journal Proceedings of the National Academy of Sciences in March 2020.
In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.
Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.
MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.
› Verified 2 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Magnet hospitals, while widely recognized for better patient safety and outcomes, don't provide better working conditions for nurses than non-magnet hospitals, according to a new study by the University of Maryland School of Nursing.
Preclinical trials indicate that a drug candidate called OxaliTex can stop the growth of cancer cells completely. OxaliTex appears to be more potent than many other common chemotherapy drugs, with less toxicity and less rapidly counteracted by mechanisms of drug resistance. The study was reported in the journal Proceedings of the National Academy of Sciences in March 2020.
In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.
Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.
MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.
› Verified 2 days ago
| Entity Name | Night Night Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700574571 PECOS PAC ID: 1759748320 Enrollment ID: O20230613002441 |
News Archive
Magnet hospitals, while widely recognized for better patient safety and outcomes, don't provide better working conditions for nurses than non-magnet hospitals, according to a new study by the University of Maryland School of Nursing.
Preclinical trials indicate that a drug candidate called OxaliTex can stop the growth of cancer cells completely. OxaliTex appears to be more potent than many other common chemotherapy drugs, with less toxicity and less rapidly counteracted by mechanisms of drug resistance. The study was reported in the journal Proceedings of the National Academy of Sciences in March 2020.
In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.
Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.
MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bridgette A Bumann, CRNA 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-5621 | Bridgette A Bumann, CRNA 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-5621 |
News Archive
Magnet hospitals, while widely recognized for better patient safety and outcomes, don't provide better working conditions for nurses than non-magnet hospitals, according to a new study by the University of Maryland School of Nursing.
Preclinical trials indicate that a drug candidate called OxaliTex can stop the growth of cancer cells completely. OxaliTex appears to be more potent than many other common chemotherapy drugs, with less toxicity and less rapidly counteracted by mechanisms of drug resistance. The study was reported in the journal Proceedings of the National Academy of Sciences in March 2020.
In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.
Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.
MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.
› Verified 2 days ago
Ashley Heule, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-371-7635 | |
Julie Honeyman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6355 | |
Todd D Underdahl, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 737 Broadway, Fargo, ND 58122 Phone: 701-234-6258 Fax: 701-234-7334 | |
Katie C Busker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 737 Broadway, Fargo, ND 58122 Phone: 701-234-6258 | |
Jordan Idso, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2868 | |
Lindsey K Holter, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 | |
Joshua Keith Maliske, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2000 |